Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 23 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 10618869

    Oligo-benzamide compounds and their use

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  2. US 10620204

    Antibody-mediated neutralization of Ebola viruses

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  3. US 10617709

    miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  4. US 10603311

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  5. US 10596247

    Methods and compositions for attenuated chlamydia as vaccine and vector

    The Board of Regents of the University of Texas System · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  6. US 10598665

    Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

    The Board of Regents of the University of Texas System · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  7. US 10589003

    Methods for coating surfaces with antimicrobial agents

    The Board of Regents of the University of Texas System · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  8. US 10590171

    Exosomes and methods of making and using the same

    The Board of Regents of the University of Texas System · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  9. US 10583145

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  10. US 10577344

    Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

    The Board of Regents of the University of Texas System · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  11. US 10576096

    Tumor-selective combination therapy

    The Board of Regents of the University of Texas System · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  12. US 10570183

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  13. US 10570186

    Chimeric antigen receptors (CAR) to selectively target protein complexes

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  14. US 10569067

    Controlled release nanoparticulate matter delivery system

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  15. US 10570382

    Transposase polypeptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  16. US 10562849

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  17. US 10561763

    Oxygen generating biomaterial

    The Board of Regents of the University of Texas System · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  18. US 10563204

    Methods of treating cancer harboring hemizygous loss of TP53

    The Board of Regents of the University of Texas System · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  19. US 10537635

    Detection of arginine methylation of EGFR for prediction of resistance to therapy

    The Board of Regents of the University of Texas System · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  20. US 10538579

    Bispecific pertussis antibodies

    The Board of Regents of the University of Texas System · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  21. US 10538762

    Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat

    The Board of Regents of the University of Texas System · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  22. US 10533997

    Reverse genetics system of Zika virus

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  23. US 10533186

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  24. US 10533227

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted